# Comparison of Chemical Peeling Agent With Transamine for Treatment of Melasma

> **NCT05362500** · PHASE1 · COMPLETED · sponsor: **Combined Military Hospital Abbottabad** · enrollment: 54 (actual)

## Conditions studied

- Melasma

## Interventions

- **DRUG:** Glycolic Acid 70%
- **DRUG:** Tranexamic acid injection

## Key facts

- **NCT ID:** NCT05362500
- **Lead sponsor:** Combined Military Hospital Abbottabad
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-01
- **Primary completion:** 2021-11-30
- **Final completion:** 2021-11-30
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2022-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05362500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05362500, "Comparison of Chemical Peeling Agent With Transamine for Treatment of Melasma". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05362500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*